Active cytomegalovirus retinitis after the start of antiretroviral therapy.
David HeidenNiNi TunFrank N SmithuisJeremy David KeenanCatherine E OldenburgGary N HollandW Lawrence DrewPublished in: The British journal of ophthalmology (2018)
Patients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first entering care with advanced HIV infection and vulnerability to reactivation of latent CMV infection should be screened immediately for CMV retinitis by dilated indirect ophthalmoscopy and treated with specific anti-CMV therapy without delay, in addition to cART.
Keyphrases
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv positive
- hiv infected patients
- hiv aids
- healthcare
- end stage renal disease
- newly diagnosed
- epstein barr virus
- palliative care
- chronic kidney disease
- climate change
- drug induced
- patient reported outcomes
- smoking cessation
- patient reported
- cell therapy